Healthcare provider profile · identity verified

Samuel E. Steffen, M.D.

Family Practice · LEXINGTON, IL · NPI 1790704435

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	655	153
Levothyroxine Sodium	Levothyroxine Sodium	597	123
Amlodipine Besylate	Amlodipine Besylate	581	123
Lisinopril	Lisinopril	523	121
Rosuvastatin Calcium	Rosuvastatin Calcium	466	121
Eliquis	Apixaban	454	51
Losartan Potassium	Losartan Potassium	423	99
Potassium Chloride	Potassium Chloride	348	57
Metoprolol Succinate	Metoprolol Succinate	299	62
Furosemide	Furosemide	289	50
Simvastatin	Simvastatin	260	61
Omeprazole	Omeprazole	254	53
Tamsulosin Hcl	Tamsulosin Hcl	237	48
Metformin Hcl	Metformin Hcl	214	45
Hydrochlorothiazide	Hydrochlorothiazide	209	51
Pantoprazole Sodium	Pantoprazole Sodium	187	37
Tramadol Hcl	Tramadol Hcl	183	39
Citalopram Hbr	Citalopram Hydrobromide	179	35
Alprazolam	Alprazolam	172	41
Gabapentin	Gabapentin	170	35
Trazodone Hcl	Trazodone Hcl	166	34
Sertraline Hcl	Sertraline Hcl	161	34
Quetiapine Fumarate	Quetiapine Fumarate	154	15
Montelukast Sodium	Montelukast Sodium	147	37
Warfarin Sodium	Warfarin Sodium	130	17
Glipizide Er	Glipizide	121	35
Metoprolol Tartrate	Metoprolol Tartrate	115	28
Fluticasone Propionate	Fluticasone Propionate	113	36
Lorazepam	Lorazepam	111	27
Famotidine	Famotidine	110	23
Fluoxetine Hcl	Fluoxetine Hcl	109	18
Escitalopram Oxalate	Escitalopram Oxalate	105	28
Metformin Hcl Er	Metformin Hcl	103	30
Torsemide	Torsemide	103	14
Pravastatin Sodium	Pravastatin Sodium	101	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	98	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	18
Clopidogrel	Clopidogrel Bisulfate	91	18
Fenofibrate	Fenofibrate	91	24
Allopurinol	Allopurinol	88	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	22
Mirtazapine	Mirtazapine	85	19
Doxycycline Hyclate	Doxycycline Hyclate	84	61
Duloxetine Hcl	Duloxetine Hcl	84	21
Carvedilol	Carvedilol	82	18
Donepezil Hcl	Donepezil Hcl	82	11
Atenolol	Atenolol	81	19
Celecoxib	Celecoxib	75	14
Oxybutynin Chloride Er	Oxybutynin Chloride	74	14
Jardiance	Empagliflozin	73	13
Cephalexin	Cephalexin	72	46
Latanoprost	Latanoprost	66	suppressed
Spironolactone	Spironolactone	65	13
Ozempic	Semaglutide	64	15
Triamcinolone Acetonide	Triamcinolone Acetonide	63	49
Sucralfate	Sucralfate	62	suppressed
Memantine Hcl	Memantine Hcl	61	suppressed
Amoxicillin	Amoxicillin	58	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	19
Oxybutynin Chloride	Oxybutynin Chloride	58	suppressed
Prednisone	Prednisone	58	30
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	57	15
Albuterol Sulfate Hfa	Albuterol Sulfate	55	31
Bupropion Xl	Bupropion Hcl	55	16
Myrbetriq	Mirabegron	53	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	12
Divalproex Sodium	Divalproex Sodium	46	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	34
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	suppressed
Azithromycin	Azithromycin	41	32
Buspirone Hcl	Buspirone Hcl	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	39	suppressed
Ezetimibe	Ezetimibe	39	suppressed
Valacyclovir	Valacyclovir Hcl	37	17
Carbidopa-Levodopa	Carbidopa/Levodopa	36	suppressed
Nystop	Nystatin	35	16
Januvia	Sitagliptin Phosphate	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Digoxin	Digoxin	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Spiriva Handihaler	Tiotropium Bromide	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	24
Finasteride	Finasteride	27	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Rivastigmine	Rivastigmine Tartrate	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Albuterol Sulfate	Albuterol Sulfate	25	14
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Colestipol Hcl	Colestipol Hcl	24	suppressed
Baclofen	Baclofen	23	13
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Methylprednisolone	Methylprednisolone	22	19
Rivastigmine	Rivastigmine	22	suppressed
Folic Acid	Folic Acid	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Nystatin	Nystatin	18	12
Ondansetron Hcl	Ondansetron Hcl	18	15
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Xarelto	Rivaroxaban	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Clonazepam	Clonazepam	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Lithium Carbonate Er	Lithium Carbonate	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Gemtesa	Vibegron	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Metolazone	Metolazone	12	suppressed
Nyamyc	Nystatin	12	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	12	11
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Desipramine Hcl	Desipramine Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error